These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 32503630)
1. A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma. Li Y; Lu S; Lan M; Peng X; Zhang Z; Lang J J Transl Med; 2020 Jun; 18(1):223. PubMed ID: 32503630 [TBL] [Abstract][Full Text] [Related]
2. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. Xu HH; Wang HL; Xing TJ; Wang XQ Front Immunol; 2022; 13():851622. PubMed ID: 35924232 [TBL] [Abstract][Full Text] [Related]
3. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of serum tumor-markers based nomogram to predict the prognostic value of patients with cervical adenocarcinoma. Liu Y; Shi L; Chen K; Ye W Curr Probl Cancer; 2022 Dec; 46(6):100899. PubMed ID: 36270166 [TBL] [Abstract][Full Text] [Related]
5. A Genomic-Clinicopathologic Nomogram Predicts Survival for Patients with Laryngeal Squamous Cell Carcinoma. Cui J; Wen Q; Tan X; Chen Z; Liu G Dis Markers; 2019; 2019():5980567. PubMed ID: 31827637 [TBL] [Abstract][Full Text] [Related]
6. Nomogram based on MRI and clinical features to predict progression-free survival in patients with stage IIIC1r cervical squamous cell carcinoma: A two-center study. Luo WX; Ding XM; Cheng JM; Liu X; Zhou HY Clin Radiol; 2024 Aug; 79(8):e1031-e1039. PubMed ID: 38749826 [TBL] [Abstract][Full Text] [Related]
7. New biomarkers exploration and nomogram construction of prognostic and immune-related adverse events of advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors. Lin X; Chen X; Long X; Zeng C; Zhang Z; Fang W; Xu P Respir Res; 2023 Feb; 24(1):64. PubMed ID: 36849947 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy. Meng J; Zhang J; Xiu Y; Jin Y; Xiang J; Nie Y; Fu S; Zhao K Mol Oncol; 2018 Feb; 12(2):196-207. PubMed ID: 29160958 [TBL] [Abstract][Full Text] [Related]
9. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer. Wang Y; Zhang L; Wang B; Cheng Y Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046 [TBL] [Abstract][Full Text] [Related]
10. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients. Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466 [TBL] [Abstract][Full Text] [Related]
11. A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification. Yang W; An L; Li Y; Qian S Aging (Albany NY); 2023 Sep; 15(18):9408-9425. PubMed ID: 37768206 [TBL] [Abstract][Full Text] [Related]
12. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer. Zhang Y; Lu H; Zhang J; Wang S Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma. Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382 [TBL] [Abstract][Full Text] [Related]
14. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma. Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269 [TBL] [Abstract][Full Text] [Related]
15. An Immune-Gene-Based Classifier Predicts Prognosis in Patients With Cervical Squamous Cell Carcinoma. Yang H; Han X; Hao Z Front Mol Biosci; 2021; 8():679474. PubMed ID: 34291084 [No Abstract] [Full Text] [Related]
16. An integrated model for prognosis in vulvar squamous cell carcinoma. Zhang T; Zhu Y; Luo J; Li J; Niu S; Chen H; Zhou F BMC Cancer; 2023 Jun; 23(1):534. PubMed ID: 37308869 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma. Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567 [TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients. Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104 [TBL] [Abstract][Full Text] [Related]
19. A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma. Tang X; Pang T; Yan WF; Qian WL; Gong YL; Yang ZG BMC Cancer; 2020 Nov; 20(1):1095. PubMed ID: 33176731 [TBL] [Abstract][Full Text] [Related]
20. Development and experimental validation of hypoxia-related gene signatures for osteosarcoma diagnosis and prognosis based on WGCNA and machine learning. Wen B; Chen J; Ding T; Mao Z; Jin R; Wang Y; Shi M; Zhao L; Yang A; Qin X; Chen X Sci Rep; 2024 Aug; 14(1):18734. PubMed ID: 39134603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]